E-selectin in vascular pathophysiology
J Zhang, S Huang, Z Zhu, A Gatt, J Liu - Frontiers in Immunology, 2024 - frontiersin.org
Selectins are a group of Ca2+-dependent, transmembrane type I glycoproteins which attract
cell adhesion and migration. E-selectin is exclusively expressed in endothelial cells, and its …
cell adhesion and migration. E-selectin is exclusively expressed in endothelial cells, and its …
The NCOR-HDAC3 co-repressive complex modulates the leukemogenic potential of the transcription factor ERG
E Kugler, S Madiwale, D Yong, JAI Thoms… - Nature …, 2023 - nature.com
The ERG (ETS-related gene) transcription factor is linked to various types of cancer,
including leukemia. However, the specific ERG domains and co-factors contributing to …
including leukemia. However, the specific ERG domains and co-factors contributing to …
RNA sequestration in P-bodies sustains myeloid leukaemia
S Kodali, L Proietti, G Valcarcel, AV López-Rubio… - Nature Cell …, 2024 - nature.com
Post-transcriptional mechanisms are fundamental safeguards of progenitor cell identity and
are often dysregulated in cancer. Here, we identified regulators of P-bodies as crucial …
are often dysregulated in cancer. Here, we identified regulators of P-bodies as crucial …
Mitochondrial-related hub genes in dermatomyositis: muscle and skin datasets-based identification and in vivo validation
S Wang, Y Tang, X Chen, S Song, X Chen… - Frontiers in …, 2024 - frontiersin.org
Background: Mitochondrial dysfunction has been implicated in the pathogenesis of
dermatomyositis (DM), a rare autoimmune disease affecting the skin and muscles. However …
dermatomyositis (DM), a rare autoimmune disease affecting the skin and muscles. However …
[HTML][HTML] Cellular and metabolic characteristics of pre-leukemic hematopoietic progenitors with GATA2 haploinsufficiency
A Rein, I Geron, E Kugler, H Fishman, E Gottlieb… - …, 2023 - ncbi.nlm.nih.gov
Mono-allelic germline disruptions of the transcription factor GATA2 result in a propensity for
developing myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML), affecting …
developing myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML), affecting …
EVI1 exerts distinct roles in AML via ERG and cyclin D1 promoting a chemoresistant and immune-suppressive environment
Y Masamoto, A Chiba, H Mizuno, T Hino… - Blood …, 2023 - ashpublications.org
Aberrant expression of ecotropic viral integration site-1 (EVI1+) is associated with very poor
outcomes in acute myeloid leukemia (AML), mechanisms of which are only partially …
outcomes in acute myeloid leukemia (AML), mechanisms of which are only partially …
Tespa1 facilitates hematopoietic and leukemic stem cell maintenance by restricting c-Myc degradation
Y Lu, L Yang, M Shen, Z Zhang, S Wang, F Chen… - Leukemia, 2023 - nature.com
Hematopoietic stem cells (HSCs) and leukemia stem cells (LSCs) have robust self-renewal
potential, which is responsible for sustaining normal and malignant hematopoiesis …
potential, which is responsible for sustaining normal and malignant hematopoiesis …
Recent infection with SARS‐CoV‐2 in donors was associated with a higher incidence of acute graft‐versus‐host disease in recipients undergoing allogeneic …
F Lin, L Xu, T Han, Z Xu, J Liu, Y He… - British Journal of …, 2024 - Wiley Online Library
The global pandemic has resulted in the common occurrence of SARS‐CoV‐2 infection in
the population. In the post‐pandemic era, it is imperative to understand the influence of …
the population. In the post‐pandemic era, it is imperative to understand the influence of …
MECOM: a bioinformatics and experimentally identified marker for the diagnosis and prognosis of lung adenocarcinoma
A Li, M Li, J Wang, J Zhou, T Yang, M Fan… - Biomarkers in …, 2024 - Taylor & Francis
Objective: We aimed to explore the clinical value of MDS1 and EVI1 complex locus
(MECOM) in lung adenocarcinoma (LUAD). Methods: Bioinformatics and experimental …
(MECOM) in lung adenocarcinoma (LUAD). Methods: Bioinformatics and experimental …
Preclinical efficacy of targeting epigenetic mechanisms in AML with 3q26 lesions and EVI1 overexpression
AML with chromosomal alterations involving 3q26 overexpresses the transcription factor
(TF) EVI1, associated with therapy refractoriness and inferior overall survival in AML …
(TF) EVI1, associated with therapy refractoriness and inferior overall survival in AML …